Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors

By Bhatia R.   Williams A.D.   Munthe H.A.  

Experimental Hematology, Vol. 30, Iss. 4, 2002-04 ,pp. : 324-332

Elsevier

Access to resources Recommend Favorite

Role of abnormal integrin-cytoskeletal interactions in impaired 1 integrin function in chronic myelogenous leukemia hematopoietic progenitors - two mechanisms with divergent biological consequences

By Bhatia R.   Munthe H.A.   Verfaillie C.M.  

Experimental Hematology, Vol. 27, Iss. 9, 1999-09 ,pp. : 1384-1396

Elsevier

Access to resources Recommend Favorite

Transforming growth factor 3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis

By Fogli M.   Carlo-Stella C.   Curti A.   Ratta M.   Tazzari P.   Ragazzi E.   Colla S.   Santucci A.M.   Tura S.   Lemoli R.M.  

Experimental Hematology, Vol. 28, Iss. 7, 2000-07 ,pp. : 775-783

Elsevier

Access to resources Recommend Favorite

Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia

By  

Current Molecular Medicine, Vol. 17, Iss. 1, 2017-04 ,pp. : 24-33

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapies for chronic myelogenous leukemia

By Jahagirdar B.N.   Miller J.S.   Shet A.   Verfaillie C.M.  

Experimental Hematology, Vol. 29, Iss. 5, 2001-05 ,pp. : 543-556

Elsevier

Access to resources Recommend Favorite